Retirement Systems of Alabama increased its stake in shares of Hamilton Lane Inc. (NASDAQ:HLNE - Free Report) by 3.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 52,746 shares of the company's stock after purchasing an additional 1,956 shares during the quarter. Retirement Systems of Alabama owned 0.10% of Hamilton Lane worth $7,842,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. CBIZ Investment Advisory Services LLC lifted its position in shares of Hamilton Lane by 27.0% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 287 shares of the company's stock worth $43,000 after purchasing an additional 61 shares during the last quarter. Arizona State Retirement System raised its stake in Hamilton Lane by 0.7% in the fourth quarter. Arizona State Retirement System now owns 11,166 shares of the company's stock valued at $1,653,000 after buying an additional 80 shares in the last quarter. HighTower Advisors LLC lifted its holdings in Hamilton Lane by 6.0% during the 4th quarter. HighTower Advisors LLC now owns 1,824 shares of the company's stock worth $270,000 after buying an additional 103 shares during the last quarter. Pictet Asset Management Holding SA lifted its holdings in Hamilton Lane by 2.0% during the 4th quarter. Pictet Asset Management Holding SA now owns 5,407 shares of the company's stock worth $801,000 after buying an additional 108 shares during the last quarter. Finally, Summit Investment Advisors Inc. boosted its position in shares of Hamilton Lane by 0.9% during the 4th quarter. Summit Investment Advisors Inc. now owns 12,245 shares of the company's stock worth $1,813,000 after acquiring an additional 109 shares in the last quarter. 97.40% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several brokerages have recently weighed in on HLNE. Morgan Stanley cut their target price on Hamilton Lane from $190.00 to $157.00 and set an "equal weight" rating on the stock in a research report on Monday, April 14th. Oppenheimer cut shares of Hamilton Lane from an "outperform" rating to a "market perform" rating in a report on Thursday, May 15th. Wells Fargo & Company lowered their target price on shares of Hamilton Lane from $166.00 to $161.00 and set an "equal weight" rating for the company in a report on Friday, May 30th. Wall Street Zen downgraded shares of Hamilton Lane from a "hold" rating to a "sell" rating in a research report on Friday, June 6th. Finally, JPMorgan Chase & Co. reduced their price target on shares of Hamilton Lane from $176.00 to $167.00 and set a "neutral" rating for the company in a research report on Tuesday, April 29th. Two investment analysts have rated the stock with a sell rating and six have given a hold rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $164.29.
Check Out Our Latest Stock Report on HLNE
Hamilton Lane Stock Performance
Shares of Hamilton Lane stock traded down $0.10 during trading on Friday, reaching $144.14. The company's stock had a trading volume of 6,419,561 shares, compared to its average volume of 510,641. The firm has a market cap of $7.72 billion, a PE ratio of 26.74 and a beta of 1.25. The company has a 50-day moving average price of $153.57 and a two-hundred day moving average price of $152.05. The company has a current ratio of 4.83, a quick ratio of 4.83 and a debt-to-equity ratio of 0.31. Hamilton Lane Inc. has a fifty-two week low of $118.08 and a fifty-two week high of $203.72.
Hamilton Lane (NASDAQ:HLNE - Get Free Report) last posted its quarterly earnings data on Thursday, May 29th. The company reported $1.21 EPS for the quarter, beating analysts' consensus estimates of $1.20 by $0.01. Hamilton Lane had a net margin of 30.50% and a return on equity of 32.94%. The company had revenue of $197.97 million for the quarter, compared to analyst estimates of $165.49 million. During the same period in the previous year, the business posted $1.38 earnings per share. Hamilton Lane's quarterly revenue was up 12.1% on a year-over-year basis. On average, analysts forecast that Hamilton Lane Inc. will post 4.97 EPS for the current year.
Hamilton Lane Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, July 7th. Shareholders of record on Friday, June 20th will be paid a dividend of $0.54 per share. The ex-dividend date of this dividend is Friday, June 20th. This is an increase from Hamilton Lane's previous quarterly dividend of $0.49. This represents a $2.16 annualized dividend and a yield of 1.50%. Hamilton Lane's dividend payout ratio is currently 40.07%.
About Hamilton Lane
(
Free Report)
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.
Further Reading

Before you consider Hamilton Lane, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hamilton Lane wasn't on the list.
While Hamilton Lane currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.